4//SEC Filing
Finizio Robert G 4
Accession 0001387131-21-005565
CIK 0000025743other
Filed
May 11, 8:00 PM ET
Accepted
May 12, 8:36 PM ET
Size
10.0 KB
Accession
0001387131-21-005565
Insider Transaction Report
Form 4
Finizio Robert G
DirectorChief Executive Officer10% Owner
Transactions
- Exercise/Conversion
Restricted Stock Units
2021-05-10−158,334→ 316,666 totalExercise: $0.00→ Common Stock (158,334 underlying) - Sale
Common Stock
2021-05-11$1.04/sh−67,697$70,405→ 17,991,637 total - Exercise/Conversion
Common Stock
2021-05-10+158,334→ 18,059,334 total
Holdings
- 2,000,000(indirect: See Footnote)
Common Stock
Footnotes (5)
- [F1]On May 10, 2021, the reporting person received 158,334 shares of issuer common stock in settlement of restricted stock units (RSUs), which vested on March 30, 2021.
- [F2]The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations.
- [F3]The reported securities are held by the Robert Finizio Revocable Trust.
- [F4]Each RSU represents a contingent right to receive one share of issuer common stock upon settlement.
- [F5]The RSUs vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023.
Documents
Issuer
TherapeuticsMD, Inc.
CIK 0000025743
Entity typeother
Related Parties
1- filerCIK 0001532235
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 8:36 PM ET
- Size
- 10.0 KB